Cargando…

Titin: a phenotype-genotype descriptive comparison of dilated cardiomyopathy

Detalles Bibliográficos
Autores principales:	Baksi, Arun J, Roberts, Angharad M, Ware, James S, Gulati, Ankur, Buchan, Rachel J, Walsh, Roddy, John, Shibu, Wilkinson, Samuel, Ali, Aamir, Assomull, Ravi G, Barton, Paul J, Prasad, Sanjay K, Pennell, Dudley J, Cook, Stuart A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045251/ http://dx.doi.org/10.1186/1532-429X-16-S1-O89

Ejemplares similares

Phenotype and Clinical Outcomes of Titin Cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2017)

Truncating Variants in Titin Independently Predict Early Arrhythmias in Patients With Dilated Cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2017)

Association of Titin-Truncating Genetic Variants With Life-threatening Cardiac Arrhythmias in Patients With Dilated Cardiomyopathy and Implanted Defibrillators
por: Corden, Ben, et al.
Publicado: (2019)

Moderate excess alcohol consumption and adverse cardiac remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2022)

Genotype positive hypertrophic cardiomyopathy is associated with myocardial perfusion abnormalities
por: Keenan, Niall G, et al.
Publicado: (2014)

Prognostic significance of midwall fibrosis in dilated cardiomyopathy
por: Gulati, Ankur, et al.
Publicado: (2012)

Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement
por: Halliday, Brian P., et al.
Publicado: (2019)

The association between ECV and microcirculation perfusion abnormalities in non-ischemic dilated cardiomyopathy
por: Ali, Aamir, et al.
Publicado: (2014)

The addition of genetic testing and cardiovascular magnetic resonance to routine clinical data for stratification of etiology in dilated cardiomyopathy
por: Amin, Ravi J., et al.
Publicado: (2022)

Role of Titin Missense Variants in Dilated Cardiomyopathy
por: Begay, Rene L., et al.
Publicado: (2015)

Reevaluating the Genetic Contribution of Monogenic Dilated Cardiomyopathy
por: Mazzarotto, Francesco, et al.
Publicado: (2020)

Evaluation of CMR predictors of right ventricular remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2016)

Genetic epidemiology of titin-truncating variants in the etiology of dilated cardiomyopathy
por: Tabish, Ali M., et al.
Publicado: (2017)

Sex‐ and age‐based differences in the natural history and outcome of dilated cardiomyopathy
por: Halliday, Brian P., et al.
Publicado: (2018)

Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional Data
por: Tayal, Upasana, et al.
Publicado: (2022)

Titin Truncating Variants in Dilated Cardiomyopathy – Prevalence and Genotype-Phenotype Correlations
por: Franaszczyk, Maria, et al.
Publicado: (2017)

Histiocytoid cardiomyopathy and microphthalmia with linear skin defects syndrome: phenotypes linked by truncating variants in NDUFB11
por: Rea, Gillian, et al.
Publicado: (2017)

Relevance of Titin Missense and Non-Frameshifting Insertions/Deletions Variants in Dilated Cardiomyopathy
por: Akinrinade, Oyediran, et al.
Publicado: (2019)

Cardiovascular magnetic resonance T2 mapping detects myocardial edema in patients with chronic dilated cardiomyopathy
por: He, Taigang, et al.
Publicado: (2012)

Antisense-mediated exon skipping: a therapeutic strategy for titin-based dilated cardiomyopathy
por: Gramlich, Michael, et al.
Publicado: (2015)

Evaluating the significance of left ventricular midwall fibrosis detected by late gadolinium enhancement imaging on left ventricular functional remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2016)

The first titin (c.59926 + 1G > A) founder mutation associated with dilated cardiomyopathy
por: Hoorntje, Edgar T., et al.
Publicado: (2017)

Dysregulated IER3 Expression is Associated with Enhanced Apoptosis in Titin-Based Dilated Cardiomyopathy
por: Zhou, Qifeng, et al.
Publicado: (2017)

Titin-Related Dilated Cardiomyopathy: The Clinical Trajectory and the Role of Circulating Biomarkers in the Clinical Assessment
por: Chmielewski, Przemysław, et al.
Publicado: (2021)

Publisher Correction: Relevance of Titin Missense and Non-Frameshifting Insertions/Deletions Variants in Dilated Cardiomyopathy
por: Akinrinade, Oyediran, et al.
Publicado: (2020)

Quantitative assessment of myocardial extracellular volume fraction in non-ischemic dilated cardiomyopathy and its relation to systolic dysfunction
por: Ali, Aamir, et al.
Publicado: (2013)

Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes
por: Walsh, Roddy, et al.
Publicado: (2017)

Titin-truncating mutations associated with dilated cardiomyopathy alter length-dependent activation and its modulation via phosphorylation
por: Vikhorev, Petr G, et al.
Publicado: (2020)

Depletion of m(6)A reader protein YTHDC1 induces dilated cardiomyopathy by abnormal splicing of Titin
por: Gao, Siyun, et al.
Publicado: (2021)

Heart Rate as a Marker of Relapse During Withdrawal of Therapy in Recovered Dilated Cardiomyopathy
por: Halliday, Brian P., et al.
Publicado: (2021)

Exposure to Elevated Nitrogen Dioxide Concentrations and Cardiac Remodeling in Patients With Dilated Cardiomyopathy
por: Fecht, DANIELA, et al.
Publicado: (2022)

Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathy
por: Schick, Revital, et al.
Publicado: (2018)

Randomized controlled trials of iron chelators for the treatment of cardiac siderosis in thalassaemia major
por: Baksi, A. John, et al.
Publicado: (2014)

The giant titin: how to evaluate its role in cardiomyopathies
por: Azad, Amar, et al.
Publicado: (2019)

Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial
por: Halliday, Brian P, et al.
Publicado: (2019)

Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction
por: Halliday, Brian P., et al.
Publicado: (2017)

Direct and indirect effect of the COVID-19 pandemic on patients with cardiomyopathy
por: Hammersley, Daniel J, et al.
Publicado: (2022)

Correction: Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathy
Publicado: (2018)

Left atrial volume is associated with mid-wall fibrosis in Dilated Cardiomyopathy
por: Fanaie, Fariba, et al.
Publicado: (2011)

Association of LA volumes and mid-wall myocardial fibrosis in the Dilated cardiomyopathy patients
por: Fanaie, Fariba, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4v9c05ljknsqq45999c35jgp0i